Strengthening Trial Design in WA at the Clinical Trials Forum
Latest from WAHTN
Strengthening Trial Design in WA at the Clinical Trials Forum
Highlights from the inaugural WA Clinical Trials Forum, including discussion of a feasibility study on childhood dementia.
8 October 2026
Discussing the trial, Repurposing Probucol for Childhood Dementia: A Phase II Feasibility Study
Presented by: Dr Arazu Sharif and Dr Bradley MacDonald
The inaugural WA Clinical Trials Forum, a new initiative of the WA Health Translation Network (WAHTN) and the Clinical Trials Enabling Platform-WA (CTEP-WA), successfully brought together clinicians, researchers and trial experts from across Western Australia to foster collaboration and strengthen the state’s clinical trials ecosystem.
Created to support a thriving clinical trials community, the forum provides a platform for researchers and clinicians to present proposed clinical trials to an expert panel and the broader clinical trials community. The initiative aims to build a community of practice focused on trial science, encouraging knowledge sharing and collaboration across disease areas and disciplines.
The first forum featured a presentation on the trial, Repurposing Probucol for Childhood Dementia: A Phase II Feasibility Study, delivered by Dr Arazu Sharif and Dr Bradley MacDonald. Attendees had the opportunity to hear about the proposed trial and participate in a robust discussion, with expert panellists providing valuable feedback to help refine and strengthen the study design before significant time and resources are committed.
Held at the Harry Perkins Institute of Medical Research and streamed online to participants across the state, the event attracted strong engagement from both in-person and virtual attendees. The presentation was followed by a networking session, allowing participants to connect, exchange ideas and build relationships within the WA clinical trials sector.
The forum highlights the importance of constructive peer review and early collaboration in developing high-quality clinical trial proposals. By creating opportunities for critical discussion and shared learning, WAHTN and CTEP-WA aim to strengthen clinical trial capability in Western Australia and improve future funding success for local researchers.
The WA Clinical Trials Forum will continue 24 November, with Dr Abdul Ihdayhid presenting on his Coronary Tomography for FiRst-Line Investigation of Stenosis before TAVI trial. Researchers interested in presenting at a future forum are encouraged to contact ctep-wa@curtin.edu.au.
WAHTN and CTEP-WA thank all presenters, panellists and attendees for contributing to the success of the inaugural forum and helping build a stronger, more connected clinical trials community in Western Australia.









